128 related articles for article (PubMed ID: 30552140)
1. Characterization of interaction and ubiquitination of phosphoenolpyruvate carboxykinase by E3 ligase UBR5.
Shen Q; Qiu Z; Wu W; Zheng J; Jia Z
Biol Open; 2018 Dec; 7(12):. PubMed ID: 30552140
[TBL] [Abstract][Full Text] [Related]
2. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.
Jiang W; Wang S; Xiao M; Lin Y; Zhou L; Lei Q; Xiong Y; Guan KL; Zhao S
Mol Cell; 2011 Jul; 43(1):33-44. PubMed ID: 21726808
[TBL] [Abstract][Full Text] [Related]
3. Structure of the HECT C-lobe of the UBR5 E3 ubiquitin ligase.
Matta-Camacho E; Kozlov G; Menade M; Gehring K
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1158-63. PubMed ID: 23027739
[TBL] [Abstract][Full Text] [Related]
4. Cryo-EM structure of the chain-elongating E3 ubiquitin ligase UBR5.
Hodáková Z; Grishkovskaya I; Brunner HL; Bolhuis DL; Belačić K; Schleiffer A; Kotisch H; Brown NG; Haselbach D
EMBO J; 2023 Aug; 42(16):e113348. PubMed ID: 37409633
[TBL] [Abstract][Full Text] [Related]
5. The MLLE domain of the ubiquitin ligase UBR5 binds to its catalytic domain to regulate substrate binding.
Muñoz-Escobar J; Matta-Camacho E; Kozlov G; Gehring K
J Biol Chem; 2015 Sep; 290(37):22841-50. PubMed ID: 26224628
[TBL] [Abstract][Full Text] [Related]
6. Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen.
Schukur L; Zimmermann T; Niewoehner O; Kerr G; Gleim S; Bauer-Probst B; Knapp B; Galli GG; Liang X; Mendiola A; Reece-Hoyes J; Rapti M; Barbosa I; Reschke M; Radimerski T; Thoma CR
Sci Rep; 2020 Nov; 10(1):20044. PubMed ID: 33208877
[TBL] [Abstract][Full Text] [Related]
7. Structure of the human UBR5 E3 ubiquitin ligase.
Wang F; He Q; Zhan W; Yu Z; Finkin-Groner E; Ma X; Lin G; Li H
Structure; 2023 May; 31(5):541-552.e4. PubMed ID: 37040767
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
9. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Nedd4-2 self-ubiquitination and stability by a PY motif located within its HECT-domain.
Bruce MC; Kanelis V; Fouladkou F; Debonneville A; Staub O; Rotin D
Biochem J; 2008 Oct; 415(1):155-63. PubMed ID: 18498246
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin chain specificities of E6AP E3 ligase and its HECT domain.
Kobayashi F; Nishiuchi T; Takaki K; Konno H
Biochem Biophys Res Commun; 2018 Feb; 496(2):686-692. PubMed ID: 29288669
[TBL] [Abstract][Full Text] [Related]
12. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD.
Bethard JR; Zheng H; Roberts L; Eblen ST
J Proteomics; 2011 Dec; 75(2):603-9. PubMed ID: 21924388
[TBL] [Abstract][Full Text] [Related]
13. UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells.
Swenson SA; Gilbreath TJ; Vahle H; Hynes-Smith RW; Graham JH; Law HC; Amador C; Woods NT; Green MR; Buckley SM
Blood; 2020 Jul; 136(3):299-312. PubMed ID: 32325489
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based small molecule cross-linkers of HECT E3 ubiquitin ligase-substrate pairs.
Park S; Ntai I; Thomas P; Konishcheva E; Kelleher NL; Statsuk AV
Biochemistry; 2012 Oct; 51(42):8327-9. PubMed ID: 23043241
[TBL] [Abstract][Full Text] [Related]
15. Selection and Characterization of a DNA Aptamer Specifically Targeting Human HECT Ubiquitin Ligase WWP1.
Tucker WO; Kinghorn AB; Fraser LA; Cheung YW; Tanner JA
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518962
[TBL] [Abstract][Full Text] [Related]
16. [Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis].
Kondratov KA; Melikova MS; Chernorudskiĭ AL; Kornilova ES
Tsitologiia; 2009; 51(7):617-23. PubMed ID: 19764654
[TBL] [Abstract][Full Text] [Related]
17. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.
Bian XL; Chen HZ; Yang PB; Li YP; Zhang FN; Zhang JY; Wang WJ; Zhao WX; Zhang S; Chen QT; Zheng Y; Sun XY; Wang XM; Chien KY; Wu Q
Nat Commun; 2017 Feb; 8():14420. PubMed ID: 28240261
[TBL] [Abstract][Full Text] [Related]
18. Regulating the human HECT E3 ligases.
Sluimer J; Distel B
Cell Mol Life Sci; 2018 Sep; 75(17):3121-3141. PubMed ID: 29858610
[TBL] [Abstract][Full Text] [Related]
19. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Shearer RF; Iconomou M; Watts CK; Saunders DN
Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
[TBL] [Abstract][Full Text] [Related]
20. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
Front Oncol; 2021; 11():634167. PubMed ID: 33777788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]